What will you learn during this webinar?
- The primary cost drivers in cell and gene therapy manufacturing
- How a CDMO leveraged platform data to reach GMP faster in a case study
- How CDMOs create value beyond capacity through expertise, innovation, and scale
- How to evaluate and select the best CDMO partner to drive cost efficiency and long- term success
Speakers:
Mark Caswell, Site Head of UK Operations, OXB
Nick Clarkson, VP, Head of Process Development, OXB
Chris Gray, VP, Head of Manufacturing & MSAT, OXB